Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized Pragmatic Clinical Trial in a Community-Based Setting Comparing STIOLTO RESPIMAT vs. ICS-LABA Plus LAMA in Patients With COPD

Next Previous
Trial Profile

Randomized Pragmatic Clinical Trial in a Community-Based Setting Comparing STIOLTO RESPIMAT vs. ICS-LABA Plus LAMA in Patients With COPD

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Jul 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Olodaterol/tiotropium bromide (Primary) ; Budesonide/formoterol/glycopyrrolate
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Acronyms AIRWISE
  • Sponsors Boehringer Ingelheim

    • Most Recent Events

    • 19 Oct 2022 Results of post hoc subgroup analysis assessing whether triple therapy reduces the risk of M/S exacerbations only in a subset of COPD patients with an elevated blood EC , presented at the CHEST Annual Meeting 2022 by Annual Meeting of the American College of Chest Physicians
    • 29 Jan 2021 Status changed from active, no longer recruiting to completed.
    • 11 Sep 2020 Planned End Date changed from 30 Aug 2020 to 30 Sep 2020.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top